{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:21Z","timestamp":1786976121987,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd013387","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000}}],"reference-count":231,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013387.pub2","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T03:33:08Z","timestamp":1646191988000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma"],"prefix":"10.1002","volume":"2022","author":[{"given":"Alexandra","family":"McAleenan","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley E","family":"Jones","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Kernohan","sequence":"additional","affiliation":[{"name":"Population Health Sciences Institute; Newcastle University; Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomos","family":"Robinson","sequence":"additional","affiliation":[{"name":"Institute of Health & Society; Newcastle University; Newcastle upon Tyne  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Kelly","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmelyn","family":"Spencer Leal","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L","family":"Faulkner","sequence":"additional","affiliation":[{"name":"Bristol Genetics Laboratory, Pathology Sciences; Southmead Hospital; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Palmer","sequence":"additional","affiliation":[{"name":"Bristol Genetics Laboratory, Pathology Sciences; Southmead Hospital; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wragg","sequence":"additional","affiliation":[{"name":"Bristol Genetics Laboratory, Pathology Sciences; Southmead Hospital; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jefferies","sequence":"additional","affiliation":[{"name":"Department of Oncology; Addenbrooke's Hospital; Cambridge UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease; UCL Queen Square Institute of Neurology; London UK"},{"name":"Division of Neuropathology; The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[{"name":"Institute of Health & Society; Newcastle University; Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian PT","family":"Higgins","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathreena M","family":"Kurian","sequence":"additional","affiliation":[{"name":"Bristol Medical School: Brain Tumour Research Centre, Public Health Sciences; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"Supp 1","key":"10.1002\/14651858.CD013387.pub2-BIB0001|cit1","first-page":"375A","article-title":"Distinction between complete and partial 1P\/19Q losses in gliomas: a novel user-friendly approach","volume":"90","author":"Ariza","year":"2010","journal-title":"Laboratory Investigation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0002|cit2","first-page":"525A","article-title":"Nanostring copy number variation assay is very sensitive in identifying EGFR amplification but is less sensitive in identifying deletions in 1p\/19q and PTEN compared to FISH in brain tumors samples","volume":"97","author":"Armanious","year":"2017","journal-title":"Laboratory Investigation"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0003|cit3","first-page":"218","article-title":"Automatic assessment of 1P36-19Q13 status in gliomas by interphase FISH assay","volume":"447","author":"Belaud-Rotureau","year":"2005","journal-title":"Virchows Archiv"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00401-005-0001-4","article-title":"Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours","volume":"111","author":"Belaud-Rotureau","year":"2006","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65134-6","article-title":"Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization","volume":"155","author":"Bigner","year":"1999","journal-title":"American Journal of Pathology"},{"issue":"8","key":"10.1002\/14651858.CD013387.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/cncr.21362","article-title":"Survival analysis of presumptive prognostic markers among oligodendrogliomas","volume":"104","author":"McLendon","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/NEN.0b013e31819a3e8c","article-title":"Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma","volume":"68","author":"Blesa","year":"2009","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/B:NEON.0000027758.10286.c1","article-title":"Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies","volume":"68","author":"Bouvier","year":"2004","journal-title":"Journal of Neuro-Oncology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5414\/NPP27378","article-title":"Detecting chromosomal alterations at 1p and 19q by FISH and DNA fragment analysis \u2013 a comparative study in human gliomas","volume":"27","author":"Broholm","year":"2008","journal-title":"Clinical Neuropathology"},{"issue":"9","key":"10.1002\/14651858.CD013387.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/modpathol.3880400","article-title":"Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections","volume":"14","author":"Burger","year":"2001","journal-title":"Modern Pathology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.humpath.2013.08.024","article-title":"Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics","volume":"45","author":"Byeon","year":"2014","journal-title":"Human Pathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/BMI.S9003","article-title":"Detection of 1p19q deletion by real-time comparative quantitative PCR","volume":"7","author":"Chaturbedi","year":"2012","journal-title":"Biomarker Insights"},{"issue":"iii","key":"10.1002\/14651858.CD013387.pub2-BIB0013|cit13","first-page":"80","article-title":"Detection of 1P\/19Q deletion in gliomas by real-time comparative quantitative PCR","volume":"3","author":"Chaturbedi","year":"2011","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0014|cit14","first-page":"428","article-title":"Molecular assessment of malignant gliomas: a combined approach using FISH and PCR for determining 1p and 19q status","volume":"6","author":"Cieply","year":"2004","journal-title":"Journal of Molecular Diagnostics"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0015|cit15","first-page":"548","article-title":"Histology trumps apparent 1P\/19Q codeletion in glioblastomas","volume":"71","author":"Clark","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nan.12031","article-title":"1p\/19q testing has no significance in the workup of glioblastomas","volume":"39","author":"Clark","year":"2013","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnen\/63.2.151","article-title":"Characterization of the 1p\/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa)","volume":"63","author":"Cowell","year":"2004","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0018|cit18","first-page":"04","article-title":"Design and validation of a gene-targeted, next-generation sequencing panel for routine diagnosis in gliomas","volume":"11","author":"D'Haene","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/gcc.20690","article-title":"Genomic aberrations in 80 cases of primary glioblastoma multiforme: pathogenetic heterogeneity and putative cytogenetic pathways","volume":"48","author":"Dahlback","year":"2009","journal-title":"Genes Chromosomes and Cancer"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/gcc.20866","article-title":"Genomic aberrations in diffuse low-grade gliomas","volume":"50","author":"Dahlback","year":"2011","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0959-8049(14)70283-7","article-title":"Sensitive and specific detection of 1p\/19q codeletion in gliomas by next generation sequencing","volume":"6","author":"Dubbink","year":"2014","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0022|cit22","first-page":"817","article-title":"Diagnostic application of targeted next-generation sequencing for detection of chromosomal losses and allelic imbalances: sensitive and specific diagnostic testing of 1p\/19q co-deletion in gliomas","volume":"17","author":"Dubbink","year":"2015","journal-title":"Journal of Molecular Diagnostics"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmoldx.2016.06.002","article-title":"Diagnostic detection of allelic losses and imbalances by next-generation sequencing: 1p\/19q co-deletion analysis of gliomas","volume":"18","author":"Dubbink","year":"2016","journal-title":"Journal of Molecular Diagnostics"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0024|cit24","first-page":"1009","article-title":"Diagnostic detection of allelic losses and imbalances by next-generation sequencing: 1p\/19q co-deletion analysis of gliomas","volume":"18","author":"Dubbink","year":"2016","journal-title":"Journal of Molecular Diagnostics"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jmoldx.2016.09.003","article-title":"Correction: diagnostic detection of allelic losses and imbalances by next-generation sequencing: 1p\/19q co-deletion analysis of gliomas [the Journal of Molecular Diagnostics (2016) 18(5) (775-786) (S1525157816300903) (10.1016\/j.jmoldx.2016.06.002]","volume":"18","author":"Dubbink","year":"2016","journal-title":"Journal of Molecular Diagnostics"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e100342","DOI":"10.1371\/journal.pone.0100342","article-title":"ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas","volume":"9","author":"Duval","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0027|cit27","first-page":"632","article-title":"ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas","volume":"73","author":"Gould","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e0132125","DOI":"10.1371\/journal.pone.0132125","article-title":"Automated analysis of 1p\/19q status by FISH in oligodendroglial tumors: rationale and proposal of an algorithm","volume":"10","author":"Duval","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013387.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/cjn.2015.253","article-title":"Automated analysis of 1p\/19q status by FISH in oligodendroglial tumours","volume":"42","author":"Gould","year":"2015","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0030|cit30","first-page":"119","article-title":"Comparison between manual and automated assessment of 1p-19q status in gliomas by FISH assay on paraffin embedded tissue: a need for standardization","volume":"40","author":"Saikali","year":"2013","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0031|cit31","first-page":"221","article-title":"Genetic characterization of oligodendrogliomas","volume":"15","author":"Drouin","year":"2007","journal-title":"Chromosome Research"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cancergencyto.2009.05.004","article-title":"Is the 1p\/19q deletion a diagnostic marker of oligodendrogliomas?","volume":"194","author":"Gadji","year":"2009","journal-title":"Cancer Genetics & Cytogenetics"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0033|cit33","first-page":"285","article-title":"Identification and impacts of genetic anomalies in the genesis, clinical development and treatment of gliomas [PhD thesis]","volume":"NR83337","author":"Gadji","year":"2010","journal-title":"ProQuest Dissertations & Theses Global"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11060-016-2066-4","article-title":"Genetic risk variants in the CDKN2A\/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma","volume":"127","author":"Ghasimi","year":"2016","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0035|cit35","first-page":"381A","article-title":"Genomic changes in gliomas by single nucleotide polymorphism (SNP) array in formalin-fixed paraffin-embedded (FFPE) tissue","volume":"1","author":"Harada","year":"2011","journal-title":"Laboratory Investigation"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmoldx.2011.05.009","article-title":"Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis","volume":"13","author":"Harada","year":"2011","journal-title":"Journal of Molecular Diagnostics"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.LAB.0000059948.67795.EF","article-title":"Molecular diagnosis of oligodendroglioma in paraffin sections","volume":"83","author":"Hatanpaa","year":"2003","journal-title":"Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.LAB.0000059948.67795.EF","article-title":"Molecular diagnosis of oligodendroglioma in paraffin sections","volume":"83","author":"Hatanpaa","year":"2003","journal-title":"Laboratory Investigation"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40478-015-0270-7","article-title":"Farewell to GBM-O: genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups","volume":"4","author":"Hinrichs","year":"2016","journal-title":"Acta Neuropathologica Communications"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/NEN.0b013e318240fa65","article-title":"The importance of 10q status in an outcomes-based comparison between 1p\/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas","volume":"71","author":"Horbinski","year":"2012","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2353\/jmoldx.2006.060012","article-title":"Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors","volume":"8","author":"Jeuken","year":"2006","journal-title":"Journal of Molecular Diagnostics"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2005.tb00120.x","article-title":"Re: multiplex ligation dependent probe amplification for the detection of 1P and 19Q loss in oligodendroglial tumors (multiple letters)","volume":"15","author":"Jeuken","year":"2005","journal-title":"Brain Pathology"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PDM.0b013e3181e961e9","article-title":"Detection of allelic status of 1p and 19q by microsatellite-based PCR versus FISH: limitations and advantages in application to patient management","volume":"20","author":"Jha","year":"2011","journal-title":"Diagnostic Molecular Pathology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0044|cit44","first-page":"118","article-title":"Detection of 1p19q codeletion by targeted sequencing for glioma genotyping [abstract]","volume":"29","author":"Kato","year":"2019","journal-title":"Brain Pathology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD013387.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"vi118","DOI":"10.1093\/neuonc\/now212.491","article-title":"Genotyping of glioma including 1P19Q codeletion by targeted sequencing","volume":"18","author":"Nishihara","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0046|cit46","first-page":"813","article-title":"Genotyping of glioma including 1p19q codeletion by targeted sequencing [SST5-2]","volume":"109","author":"Nishihara","year":"2018","journal-title":"Cancer Science"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0047|cit47","first-page":"432A","article-title":"Utility of whole genome single nucleotide polymorphism microarray (SNPM) and targeted somatic mutations analysis in the evaluation of adult brain tumors","volume":"1","author":"Kolhe","year":"2016","journal-title":"Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bpa.12003","article-title":"Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas","volume":"23","author":"Lass","year":"2013","journal-title":"Brain Pathology"},{"issue":"11","key":"10.1002\/14651858.CD013387.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/gcc.22266","article-title":"Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene","volume":"54","author":"Lhotska","year":"2015","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14735\/amko2014183","article-title":"Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification","volume":"27","author":"Lhotska","year":"2014","journal-title":"Klinicka Onkologie"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0051|cit51","volume-title":"Unbalanced changes in cancer cells genome and its role in cancer pathogenesis [PhD thesis] [Nebalancovan\u00e9 zm?ny v genomu n\u00e1dorov\u00fdch bun?k a jejich \u00faloha v patogenezi onemocn?n\u00ed]","author":"Lhotska","year":"2017"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0052|cit52","unstructured":"Mohapatra G Betensky RA Miller ER Carey B Gaumont LD Engler DA Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization 97th Annual Meeting of the American Association for Cancer Research; 2006 April 1-5; Washington (DC)"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2353\/jmoldx.2006.050109","article-title":"Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization","volume":"8","author":"Mohapatra","year":"2006","journal-title":"Journal of Molecular Diagnostics"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-019-03114-1","article-title":"Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases","volume":"142","author":"Na","year":"2019","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1750-3639.2005.tb00520.x","article-title":"Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors","volume":"15","author":"Natte","year":"2005","journal-title":"Brain Pathology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9440(10)64076-X","article-title":"Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay","volume":"158","author":"Nigro","year":"2001","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41598-019-40364-5","article-title":"Detection of chromosome structural variation by targeted next-generation sequencing and a deep learning application","volume":"9","author":"Park","year":"2019","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0058|cit58","first-page":"247","article-title":"Observations of the genomic landscape beyond 1p19q deletions and EGFR amplification in Glioma","volume":"142","author":"Paxton","year":"2014","journal-title":"Cytogenetic and Genome Research"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13039-015-0156-1","article-title":"Observations of the genomic landscape beyond 1p19q deletions and EGFR amplification in glioma","volume":"8","author":"Paxton","year":"2015","journal-title":"Molecular Cytogenetics"},{"issue":"34","key":"10.1002\/14651858.CD013387.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"57134","DOI":"10.18632\/oncotarget.19103","article-title":"Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p\/19q codeletion, and IDH1, IDH2, and TERT mutation status","volume":"8","author":"Pesenti","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/gcc.2870050411","article-title":"Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas","volume":"5","author":"Ransom","year":"1992","journal-title":"Genes Chromosomes and Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/gcc.2870050412","article-title":"Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas","volume":"5","author":"Ransom","year":"1992","journal-title":"Genes Chromosomes and Cancer"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.pas.0000213250.44822.2e","article-title":"Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors","volume":"30","author":"Scheie","year":"2006","journal-title":"American Journal of Surgical Pathology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0064|cit64","first-page":"464","article-title":"1p\/19q loss in oligodendroglial tumors-methodological, histological, radiological and clinical aspects","volume":"31","author":"Scheie","year":"2012","journal-title":"Clinical Neuropathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0065|cit65","volume-title":"1p\/19q-loss in Oligodendroglial Tumours. Methodological, Histological, Radiological and Clinical Aspects [PhD thesis]","author":"Scheie","year":"2012"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0066|cit66","first-page":"1203","article-title":"Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses","volume":"144","author":"Schrock","year":"1994","journal-title":"American Journal of Pathology"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/NEN.0b013e3182901f41","article-title":"A \"weighted\" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p\/19q codeletion in pure and mixed oligodendroglial tumors","volume":"72","author":"Senetta","year":"2013","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-018-1119-2","article-title":"Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization","volume":"35","author":"Sim","year":"2018","journal-title":"Medical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0069|cit69","first-page":"228","article-title":"Comparison of 1p19q status by FISH and whole exome sequencing and\/or array-CGH in glioblastoma","volume":"35","author":"Suh","year":"2016","journal-title":"Clinical Neuropathology"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-018-1119-2","article-title":"Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization","volume":"35","author":"Sim","year":"2018","journal-title":"Medical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0071|cit71","first-page":"228","article-title":"Comparison of 1p19q status by FISH and whole exome sequencing and\/or array-CGH in glioblastoma","volume":"35","author":"Suh","year":"2016","journal-title":"Clinical Neuropathology"},{"issue":"28","key":"10.1002\/14651858.CD013387.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1038\/sj.onc.1202759","article-title":"Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype","volume":"18","author":"Smith","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0073|cit73","first-page":"256","article-title":"Brush cytology for FISH based detection of 1p\/19q loss in oligodendroglial tumors","volume":"31","author":"Limbaeck-Stokin","year":"2012","journal-title":"Clinical Neuropathology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11060-016-2211-0","article-title":"Application of brush cytology for FISH-based detection of 1p\/19q codeletion in oligodendroglial tumors","volume":"129","author":"Srebotnik-Kirbis","year":"2016","journal-title":"Journal of Neuro-Oncology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0075|cit75","first-page":"707","article-title":"Validation of affymetrix 250K Nsp arrays for clinical use in the evaluation of genomic copy number alteration and loss of heterozygosity in cancer","volume":"14","author":"Thakur","year":"2012","journal-title":"Journal of Molecular Diagnostics"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/neuonc\/nox086","article-title":"Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma","volume":"19","author":"Thomas","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0077|cit77","unstructured":"Tsiatis AC Hafez MJ Jedlicka AE Maitra A Murphy KM Eshleman JR Use of SNP arrays to assess loss of heterozygosity in gliomas 101st Annual Meeting of American Association for Cancer Research; 2010 April 17-21; Washington (DC) 10.1158\/1538-7445.AM10-1781"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0078|cit78","first-page":"120","article-title":"Usefulness and pitfalls of 1p\/ 19q-codeletion analysis by FISH method in glioblastoma","volume":"29","author":"Uchida","year":"2019","journal-title":"Brain Pathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Wiestler B Capper D Hovestadt V Sill M Jones D Hartmann C Assessing CpG island methylator phenotype, 1p\/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial Neuro-Oncology 2014 16 12 1630 8","DOI":"10.1093\/neuonc\/nou138"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Wiestler B Capper D Hovestadt V Sill M Jones D Hartmann C Determining the glioma CpG island methylator phenotype, 1p\/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial Journal of Clinical Oncology 2014 32 15 10.1200\/jco.2014.32.15_suppl.2017","DOI":"10.1200\/jco.2014.32.15_suppl.2017"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12859-017-1626-8","article-title":"Segmentum: a tool for copy number analysis of cancer genomes","volume":"18","author":"Afyounian","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/neuonc\/not227","article-title":"Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas","volume":"16","author":"Alentorn","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/jco.2015.33.15_suppl.2038","article-title":"Prognostic model of lower grade gliomas","volume":"33","author":"Aoki","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0084|cit84","first-page":"v91","article-title":"Prognostic significance of genetic alterations from comprehensive analysis in lower-grade gliomas","volume":"5","author":"Aoki","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0085|cit85","first-page":"341","article-title":"Genomic profiling as a tool to improve diagnosis and treatment of malignant gliomas","volume":"50","author":"Assem","year":"2009","journal-title":"Proceedings of the American Association for Cancer Research Annual Meeting"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/omi.2011.0031","article-title":"Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics","volume":"16","author":"Assem","year":"2012","journal-title":"Omics a Journal of Integrative Biology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0087|cit87","first-page":"iii141","article-title":"The genetic and epigenetic context of MGMT methylation in glioma may impact the predictive and prognostic value","volume":"3","author":"Bady","year":"2013","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.humpath.2017.05.005","article-title":"Molecular classification of adult diffuse gliomas: conflicting IDH1\/IDH2, ATRX, and 1p\/19q results","volume":"69","author":"Ballester","year":"2017","journal-title":"Human Pathology"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1200\/JCO.2017.35.15_suppl.2064","article-title":"Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas","volume":"35","author":"Becker","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5414\/NP301110","article-title":"Molecular diagnostic testing of diffuse gliomas in the real-life setting: a practical approach","volume":"37","author":"Bienkowski","year":"2018","journal-title":"Clinical Neuropathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0091|cit91","first-page":"81","article-title":"Molecular characterization of brain tumors","volume":"51","author":"Boudreau","year":"2004","journal-title":"Clinical Neurosurgery"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"Brat DJ Fehrenbach A Finocchiaro G Verhaak RG Friedman W Al-Dape KD Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas New England Journal of Medicine 2015 372 26 2481 98","DOI":"10.1056\/NEJMoa1402121"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/NEN.0b013e31820c765b","article-title":"Loss of chromosome 1p\/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker","volume":"70","author":"Buckley","year":"2011","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD013387.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"vi98","DOI":"10.1093\/neuonc\/nox168.402","article-title":"Clinical and molecular analyses of long term survivors of glioblastoma","volume":"19","author":"Burgenske","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0095|cit95","first-page":"S146","article-title":"Genomic changes in 37 patients with low-grade diffuse gliomas","volume":"1","author":"Bystricka","year":"2011","journal-title":"Chromosome Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0096|cit96","first-page":"284A","article-title":"1p\/19q loss in gliomas: microsatellite amplification in comparison with FISH","volume":"86","author":"Carrato","year":"2006","journal-title":"Laboratory Investigation"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0097|cit97","first-page":"60","article-title":"A rapid, user-friendly approach for distinguishing between partial and complete 1p\/19q losses in gliomas","volume":"1","author":"Carrato","year":"2010","journal-title":"Brain Pathology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0098|cit98","first-page":"1009","article-title":"Targeted NGS in molecular subtyping of lower-grade diffuse gliomas: application of the WHO's 2016 revised criteria for CNS tumors","volume":"18","author":"Carter","year":"2016","journal-title":"Journal of Molecular Diagnostics"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0099|cit99","first-page":"289A","article-title":"Discordance in allelic losses on chromosomes 1p and 19q in gliomas","volume":"16","author":"Castilla","year":"2003","journal-title":"Modern Pathology"},{"issue":"12","key":"10.1002\/14651858.CD013387.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.bjc.6601025","article-title":"Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography","volume":"88","author":"Chernova","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0101|cit101","first-page":"688","article-title":"Assessment of 1p and 19q status in pediatric oligodendrogliomas by FISH","volume":"7","author":"Cieply","year":"2005","journal-title":"Journal of Molecular Diagnostics"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/modpathol.2009.185","article-title":"1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis","volume":"23","author":"Durand","year":"2010","journal-title":"Modern Pathology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD013387.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"vi181","DOI":"10.1093\/neuonc\/nox168.737","article-title":"Clinical sensitivity and specificity of illumina methylation array for classifying adult gliomas into who groups","volume":"19","author":"Eckel-Passow","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2990.2007.00835.x","article-title":"DNA extraction by FTATM technology: application for rapid detection of 1p\/19q deletions in gliomas","volume":"33","author":"Fontaine","year":"2007","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2008.09.017","article-title":"Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity","volume":"190","author":"Franco-Hernandez","year":"2009","journal-title":"Cancer Genetics & Cytogenetics"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1130-1473(09)70178-2","article-title":"Identification of genetic alterations by multiple ligation-dependent probe amplification (MLPA) analysis in oligodendrogliomas","volume":"20","author":"Franco-Hernandez","year":"2009","journal-title":"Neurocirugia (Asturias, Spain)"},{"issue":"24","key":"10.1002\/14651858.CD013387.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1158\/0008-5472.CAN-05-1886","article-title":"Gene expression profiles associated with treatment response in oligodendrogliomas","volume":"65","author":"French","year":"2005","journal-title":"Cancer Research"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/neuonc\/now132","article-title":"Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies","volume":"18","author":"Garber","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jnen\/64.1.10","article-title":"Molecular genetic analysis of oligodendroglial tumors","volume":"64","author":"Hartmann","year":"2005","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0110|cit110","first-page":"221","volume-title":"Developments in Neuroscience, Proceedings","author":"Hashimoto","year":"2002"},{"issue":"12","key":"10.1002\/14651858.CD013387.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/neuonc\/noy128","article-title":"Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics","volume":"20","author":"Hench","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0112|cit112","first-page":"321A","article-title":"Chordoid glioma: molecular characterization of four cases","volume":"88","author":"Horbinski","year":"2008","journal-title":"Laboratory Investigation"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0113|cit113","first-page":"526","article-title":"Prospective comparison of FISH versus PCR-based microsatellite LOH in the evaluation of gliomas for 1p\/19q codeletion","volume":"70","author":"Horbinski","year":"2011","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Ida C Zepeda-Mendoza C Praska C Balcom J Swanson K Barr Fritcher E Recurrent unusual patterns in clinical molecular profiling of adult diffuse gliomas Journal of Neuropathology and Experimental Neurology 2018 77 6 482","DOI":"10.1093\/neuonc\/noy148.680"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1440-1789.2008.00863.x","article-title":"Chromosome 1p loss evaluation in anaplastic oligodendrogliomas","volume":"28","author":"Idbaih","year":"2008","journal-title":"Neuropathology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humpath.2012.07.022","article-title":"Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report","volume":"44","author":"Joo","year":"2013","journal-title":"Human Pathology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11060-012-0977-2","article-title":"The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas","volume":"110","author":"Juratli","year":"2012","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0118|cit118","first-page":"v95","article-title":"Integrated genomic analysis of oligodendroglial tumors identifies distinct molecular subgroups within 1p\/19q co-deleted oligodendrogliomas","volume":"5","author":"Kamoun","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0119|cit119","first-page":"s28","article-title":"Expanding on WHO guideline compliant molecular testing of central nervous system tumours by low density whole genome sequencing","volume":"473","author":"Kashofer","year":"2018","journal-title":"Virchows Archiv"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD013387.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"vi117","DOI":"10.1093\/neuonc\/now212.489","article-title":"Results of molecular profiling for recurrent malignant gliomas reveal significant changes in biomarkers compared to mostly treatment naive tumors that could impact treatment decision","volume":"18","author":"Kim","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0121|cit121","first-page":"386","article-title":"Analysis of genetic dosage anomalies using comparative genomic hybridization array (CGHa) in human oligodendrogliomas","volume":"45","author":"Kitange","year":"2004","journal-title":"Proceedings of the American Association for Cancer Research Annual Meeting"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/gcc.20108","article-title":"Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas","volume":"42","author":"Kitange","year":"2005","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1155\/2010\/279317","article-title":"Glioblastomas with oligodendroglial component \u2013 common origin of the different histological parts and genetic subclassification","volume":"33","author":"Klink","year":"2010","journal-title":"Analytical Cellular Pathology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13402-011-0034-8","article-title":"Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification","volume":"34","author":"Klink","year":"2011","journal-title":"Cellular Oncology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1215\/15228517-2009-011","article-title":"Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: a report from EORTC study 26951","volume":"11","author":"Kouwenhoven","year":"2009","journal-title":"Neuro-Oncology"},{"issue":"12","key":"10.1002\/14651858.CD013387.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/ijc.24303","article-title":"Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors","volume":"124","author":"Kuo","year":"2009","journal-title":"International Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"e67139","DOI":"10.1371\/journal.pone.0067139","article-title":"Genetic and epigenetic alterations in primary-progressive paired oligodendroglial tumors","volume":"8","author":"Kuo","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0128|cit128","first-page":"43","article-title":"Molecular subgrouping of gliomatosis cerebri according to the 2016 World Health Organization classification of tumors of the central nervous system","volume":"29","author":"Kwon","year":"2019","journal-title":"Brain Pathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0129|cit129","first-page":"iii145","article-title":"Genome-wide CNV analysis identifies loci putatively associated with delayed time to first recurrence in IDH-mutant low-grade astrocytomas","volume":"3","author":"Lautenschlaeger","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0130|cit130","first-page":"660","article-title":"Implementation of the 2016 who classification for infiltrating glioma: the VGH experience","volume":"98","author":"Levine","year":"2018","journal-title":"Laboratory Investigation"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0131|cit131","first-page":"789","article-title":"Development of a 1p19q LOH assay for glioma patients using capillary electrophoresis","volume":"16","author":"Liu","year":"2014","journal-title":"Journal of Molecular Diagnostics"},{"issue":"2-3","key":"10.1002\/14651858.CD013387.pub2-BIB0132|cit132","first-page":"165","article-title":"Multiple alterations of chromosome arms 1p and 19q detected by FISH analysis correlate with LOH heterogeneity in gliomas","volume":"46","author":"Magnani","year":"2003","journal-title":"Annales de Genetique"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-004-3347-x","article-title":"Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval","volume":"72","author":"Martinez","year":"2005","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.humpath.2011.05.007","article-title":"Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion","volume":"43","author":"Marucci","year":"2012","journal-title":"Human Pathology"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/cncr.21338","article-title":"The prognostic impact of histology and 1p\/19q status in anaplastic oligodendroglial tumors","volume":"104","author":"McDonald","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-010-0773-z","article-title":"Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas","volume":"121","author":"Mohapatra","year":"2011","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0137|cit137","first-page":"145","article-title":"Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study","volume":"25","author":"Molinari","year":"2010","journal-title":"International Journal of Molecular Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0138|cit138","first-page":"483","article-title":"Neuroradiology concordance with neuropathology in predicting 1p\/19q-codeletion in IDH-mutant lower-grade gliomas","volume":"77","author":"Mrachek","year":"2018","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-013-1130-9","article-title":"Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors","volume":"126","author":"Mur","year":"2013","journal-title":"Acta Neuropathologica"},{"issue":"12","key":"10.1002\/14651858.CD013387.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/PAS.0b013e31823456e6","article-title":"Papillary glioneuronal tumors: a review of clinicopathologic and molecular genetic studies","volume":"35","author":"Myung","year":"2011","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0141|cit141","first-page":"55","article-title":"Fluorescence in situ hybridization (FISH) for 1p\/19q in oligodendrogliomas \u2013 the need for consensus criteria and uniform guidelines","volume":"1","author":"Narasimhaiah","year":"2010","journal-title":"Brain Pathology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0142|cit142","first-page":"635","article-title":"Disseminated oligodendroglioma-like leptomeningeal neoplasm in a 31 year-old patient","volume":"74","author":"Neill","year":"2015","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0143|cit143","first-page":"147","article-title":"Loss of heterozygosity on chromosomes 1 and 19 in primary brain tumors","volume":"169","author":"Nielsen","year":"2007","journal-title":"Ugeskrift for Laeger"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0144|cit144","first-page":"428","article-title":"Molecular diagnosis of oligodendrogliomas using capillary electrophoresis to detect loss of heterozygosity on chromosomes 1p and 19q","volume":"6","author":"Parizi-Robinson","year":"2004","journal-title":"Journal of Molecular Diagnostics"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0145|cit145","first-page":"802","article-title":"Oligodendrogliomas with LOH 1P\/19Q: identifying genes associated with therapeutic sensitivity","volume":"10","author":"Payne","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0146|cit146","first-page":"435A","article-title":"Molecularly defined adult gliomas with known ATRX status: does TERT have an additional prognostic role","volume":"1","author":"Pekmezci","year":"2016","journal-title":"Laboratory Investigation"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0147|cit147","doi-asserted-by":"crossref","unstructured":"Pietsch T Gessi M Muhlen A D\u00f6rner E Last A Sundar P Implementation of next generation copy number and mutational analysis in routine neuropathology: molecular inversion profiling is a helpful tool in differential diagnostics and prognostification of pediatric brain tumors Neuro-Oncology 2015 3 iii30 iii","DOI":"10.1093\/neuonc\/nov061.123"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0148|cit148","first-page":"434A","article-title":"Utility of whole genome amplification (WGA) to enable virtual karyotyping with SNP arrays in paraffin-embedded brain tumor biopsies with limited tissue","volume":"1","author":"Pina-Oviedo","year":"2012","journal-title":"Laboratory Investigation"},{"issue":"8","key":"10.1002\/14651858.CD013387.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clon.2015.04.008","article-title":"FISHing tips: what every clinician should know about 1p19q analysis in gliomas using fluorescence in situ hybridisation","volume":"27","author":"Pinkham","year":"2015","journal-title":"Clinical Oncology (Royal College of Radiologists)"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00428-007-0562-9","article-title":"Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis","volume":"452","author":"Pinto","year":"2008","journal-title":"Virchows Archiv"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/neuonc\/nov015","article-title":"Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma","volume":"17","author":"Ramkissoon","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0152|cit152","first-page":"302A","article-title":"Detection of 1p\/19q deletion by microdissection genotyping identifies high grade gliomas patients with long survival","volume":"82","author":"Rolston","year":"2002","journal-title":"Laboratory Investigation"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0153|cit153","first-page":"698","article-title":"Comparison of SNP array karyotyping, FISH and LOH analysis for diagnosis of gliomas","volume":"14","author":"Roy","journal-title":"Journal of Molecular Diagnostics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0154|cit154","first-page":"S17","article-title":"Development of a novel fish probe for detection of 1p\/19q codeletion in routine glioma diagnosis","volume":"246","author":"Satomi","year":"2018","journal-title":"Journal of Pathology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0155|cit155","first-page":"124","article-title":"Development of a novel FISH probe for detection of 1p\/19q codeletion in routine glioma diagnosis","volume":"29","author":"Satomi","year":"2019","journal-title":"Brain Pathology"},{"issue":"19 Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1158\/1538-7445.AM2014-3426","article-title":"A novel approach to copy number assessment by whole genome sequencing reveals extensive spatial heterogeneity in diffuse low-grade glioma","volume":"74","author":"Scheinin","year":"2014","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0157|cit157","first-page":"S400","article-title":"Patterns of 1p\/19q chromosomal abnormalities among glial neoplasms","volume":"1","author":"Schiavo","year":"2009","journal-title":"Virchows Archiv"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0158|cit158","first-page":"815","article-title":"Improving molecular diagnostics with 450K methylation array in clinical neuropathology","volume":"17","author":"Serrano","year":"2015","journal-title":"Journal of Molecular Diagnostics"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/NP301104","article-title":"Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations","volume":"37","author":"Tauziede-Espariat","year":"2018","journal-title":"Clinical Neuropathology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0160|cit160","first-page":"576","article-title":"Analysis of genetic alterations in microdissected gliomas","volume":"10","author":"Walker","year":"2000","journal-title":"Brain Pathology"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/cns.15.28","article-title":"Molecular diagnostics: techniques and recommendations for 1p\/19q assessment","volume":"4","author":"Woehrer","year":"2015","journal-title":"CNS Oncology"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD013387.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1200\/jco.2015.33.15_suppl.2058","article-title":"Tumor profiling on 1245 gliomas and paired tumor study on 19 high grade gliomas","volume":"33","author":"Xiu","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10014-018-0322-3","article-title":"Impact of PCR-based molecular analysis in daily diagnosis for the patient with gliomas","volume":"35","author":"Yokogami","year":"2018","journal-title":"Brain Tumor Pathology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1349-7006.2002.tb02170.x","article-title":"Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their imbalance in brain tumors","volume":"93","author":"Yoshimoto","year":"2002","journal-title":"Japanese Journal of Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12367","article-title":"Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel","volume":"27","author":"Zacher","year":"2017","journal-title":"Brain Pathology"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1535-7163.MCT-18-1122","article-title":"Prospective clinical sequencing of adult glioma","volume":"18","author":"Zheng","year":"2019","journal-title":"Molecular Cancer Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.praneu.2011.02.010","article-title":"Prognostic and predictive biomarkers of gliomas in adults","volume":"2","author":"Ducray","year":"2011","journal-title":"Pratique Neurologique - FMC"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0168|cit168","volume-title":"Prevalence of Alterations at Microsatellite Loci on 1p and 19q in Primary Human Gliomas (thesis)","year":"2006"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0169|cit169","first-page":"1216","article-title":"Genetic and epigenetic alterations of oligodendrogliomas revealed by gene mapping and pathway transcriptome profiling","volume":"44","author":"McDonald","year":"2003","journal-title":"Proceedings of the American Association for Cancer Research Annual Meeting"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0170|cit170","unstructured":"Meunier N Fluorescence in situ (FISH) assay for the detection of 1p36 and 19q13 deletions in gliomas (technical improvements for a retrospective study of 25 patients) hdl.handle.net\/10068\/770157"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0171|cit171","unstructured":"Monnot S 1p \/ 19q deletions, in gliomas (study of 46 Nice patients and implementation of new detection methods) hdl.handle.net\/10068\/803964"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0172|cit172","first-page":"702","article-title":"Validation of a semi-automated loss of heterozygosity assay for chromosomes 1 and 19 in human gliomas using commercially available fluorescent-labeled human MapPairs(R) and capillary electrophoresis","volume":"44","author":"Sebastian","year":"2003","journal-title":"Proceedings of the American Association for Cancer Research Annual Meeting"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0173|cit173","unstructured":"Access to innovative molecular diagnostic PROfiling for paediatric brain tumours anzctr.org.au\/ACTRN12618000006246"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0174|cit174","unstructured":"Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p\/19q, and mutation of IDH1\/2 upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000003871"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0175|cit175","unstructured":"Genetic analysis of brain tumors clinicaltrials.gov\/ct2\/show\/NCT00031538"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0176|cit176","unstructured":"Study of tissue and blood samples from patients with high-grade glioma clinicaltrials.gov\/ct2\/show\/NCT01004887"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0177|cit177","unstructured":"Precision medicine for children with cancer clinicaltrials.gov\/ct2\/show\/NCT03336931"},{"issue":"5","key":"10.1002\/14651858.CD013387.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0272989X08319957","article-title":"Bivariate random effects meta-analysis of ROC curves","volume":"28","author":"Arends","year":"2008","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0179|cit179","unstructured":"Bossuyt PM Chapter 4: Understanding the design of test accuracy studies Draft version (21 May 2021) for inclusion. In: Deeks JJ, Bossuyt PM, Leeflang MM, Takwoingi Y, editor(s). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 2. London: Cochrane."},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"7697","key":"10.1002\/14651858.CD013387.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathologica"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0183|cit183","unstructured":"CCEMG \u2013 EPPI-Centre CCEMG \u2013 EPPI-Centre Cost Converter (v.1.6, 29 April 2019) eppi.ioe.ac.uk\/costconversion\/"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-015-1906-y","article-title":"Prognostic significance of relative 1p\/19q codeletion in oligodendroglial tumors","volume":"125","author":"Chamberlain","year":"2015","journal-title":"Journal of Neuro-Oncology"},{"issue":"12","key":"10.1002\/14651858.CD013387.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","article-title":"Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach","volume":"59","author":"Chu","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"486","key":"10.1002\/14651858.CD013387.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1198\/jasa.2009.0017","article-title":"Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard","volume":"104","author":"Chu","year":"2009","journal-title":"Journal of the American Statistical Association"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T","article-title":"Grading of astrocytomas: a simple and reproducible method","volume":"62","author":"Daumas-Duport","year":"1988","journal-title":"Cancer"},{"issue":"9","key":"10.1002\/14651858.CD013387.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1541-0420.2012.01773.x","article-title":"Bayesian meta-analysis of the accuracy of a test for tuberculous pleuritis in the absence of a gold standard reference","volume":"68","author":"Dendukuri","year":"2012","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-60761-947-5_8","article-title":"Multiplex ligation-dependent probe amplification (MLPA(R)) for the detection of copy number variation in genomic sequences","volume":"688","author":"Eijk-Van Os","year":"2011","journal-title":"Methods in Molecular Biology"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"7650","key":"10.1002\/14651858.CD013387.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biostatistics\/kxl004","article-title":"A unification of models for meta-analysis of diagnostic accuracy studies","volume":"8","author":"Harbord","year":"2007","journal-title":"Biostatistics"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.inat.2016.06.008","article-title":"Role of chromosomal 1p\/19q co-deletion on the prognosis of oligodendrogliomas: a systematic review and meta-analysis","volume":"5","author":"Hu","year":"2016","journal-title":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0196|cit196","unstructured":"Neuro-oncology top 10 www.jla.nihr.ac.uk\/priority-setting-partnerships\/neuro-oncology\/top-10-priorities\/"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-019-0668-8","article-title":"Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre","volume":"7","author":"Jaunmuktane","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"issue":"20","key":"10.1002\/14651858.CD013387.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-014-1526-y","article-title":"Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors","volume":"120","author":"Jiang","year":"2014","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1541-0420.2009.01330.x","article-title":"Identifiability of models for multiple diagnostic testing in the absence of a gold standard","volume":"66","author":"Jones","year":"2010","journal-title":"Biometrics"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathologica"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathology"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS \u2013 a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Statistics and Computing"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-Of-Bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40273-014-0198-y","article-title":"A review of the economic burden of glioblastoma and the cost effectiveness of pharmacologic treatments","volume":"32","author":"Messali","year":"2014","journal-title":"PharmacoEconomics"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0206|cit206","first-page":"1","volume-title":"Developing NICE Guidelines: the Manual","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0207|cit207","unstructured":"National Institute for Health and Care Excellence Brain tumours (primary) and brain metastases in adults www.nice.org.uk\/guidance\/ng99"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a state of the science review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013387.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S2352-4642(19)30342-6","article-title":"DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study","volume":"4","author":"Pickles","year":"2020","journal-title":"Lancet Child & Adolescent Health"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD013387.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/neuonc\/not092","article-title":"Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p\/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases","volume":"15","author":"Ren","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"19","key":"10.1002\/14651858.CD013387.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"7653","key":"10.1002\/14651858.CD013387.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/9781119536604.ch20","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Shemilt","year":"2019"},{"issue":"20","key":"10.1002\/14651858.CD013387.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1158\/1078-0432.CCR-09-0867","article-title":"Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p\/19q loss","volume":"15","author":"Snuderl","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/annonc\/mdu050","article-title":"High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Stupp","year":"2014","journal-title":"Annals of Oncology"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-158-7-201304020-00006","article-title":"Empirical evidence of the importance of comparative studies of diagnostic test accuracy","volume":"158","author":"Takwoingi","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0218|cit218","unstructured":"TreeAge Pro 2021, R1 TreeAge Software 2021"},{"issue":"4","key":"10.1002\/14651858.CD013387.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2307\/2530967","article-title":"The effect of conditional dependence on the evaluation of diagnostic tests","volume":"41","author":"Vacek","year":"1985","journal-title":"Biometrics"},{"issue":"3","key":"10.1002\/14651858.CD013387.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"den Bent","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD013387.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/neuonc\/nop075","article-title":"Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses","volume":"12","author":"Vogazianou","year":"2010","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1002\/14651858.CD013387.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0895-4356(99)00086-4","article-title":"Meta-analysis of diagnostic tests with imperfect reference standards","volume":"52","author":"Walter","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013387.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1002\/14651858.CD013387.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0226|cit226","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-84988-6","volume-title":"Histological Typing of Tumours of the Central Nervous System","author":"Kleihues","year":"1993"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0227|cit227","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System","author":"Kleihues","year":"2000"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0228|cit228","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"key":"10.1002\/14651858.CD013387.pub2-BIB0229|cit229","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"issue":"1","key":"10.1002\/14651858.CD013387.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/neuonc\/not145","article-title":"Loss of heterozygosity 1p\/19q and survival in glioma: a meta-analysis","volume":"16","author":"Zhao","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1002\/14651858.CD013387.pub2-BIB0231|cit231","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013387","article-title":"Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma","author":"McAleenan","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:21:04Z","timestamp":1756686064000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013387.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":231,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013387.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}